Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
British Journal of Clinical Pharmacology
|
January 25, 2021
Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5-fluorouracil toxicity
Seid Hamzic, Dominic Schärer, Steven M Offer, et al.
The Journal of Clinical Investigation
|
February 27, 2014
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance
Camilla Jandus, Kayluz Frias Boligan, Obinna Chijioke, et al.
Journal for Immunotherapy of Cancer
|
January 8, 2022
Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)
Marc Wehrli, Kathleen Gallagher, Yi-Bin Chen, et al.
Cancer Cell
|
April 22, 2022
Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia
Mark B Leick, Harrison Silva, Irene Scarfò, et al.
Blood Cancer Discovery
|
January 11, 2022
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies
Stefanie R Bailey, Sonika Vatsa, Rebecca C Larson, et al.
Science Translational Medicine
|
June 5, 2024
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics
Felix Korell, Michael L Olson, Diego Salas-Benito, et al.
Blood
|
November 21, 2024
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
Harrison J Silva, Grace Martin, Filippo Birocchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 3, 2020
IgA Triggers Cell Death of Neutrophils When Primed by Inflammatory Mediators
Marc Wehrli, Christoph Schneider, Fabiola Cortinas-Elizondo, et al.
Science Translational Medicine
|
June 4, 2025
IFN-γ-resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models
Stefanie R Bailey, Hana N Takei, Giulia Escobar, et al.
Blood Advances
|
March 25, 2026
Real-world experience with Tabelecleucel within and beyond the approval label
Kiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
British Journal of Clinical Pharmacology
|
January 25, 2021
Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5-fluorouracil toxicity
Seid Hamzic, Dominic Schärer, Steven M Offer, et al.
The Journal of Clinical Investigation
|
February 27, 2014
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance
Camilla Jandus, Kayluz Frias Boligan, Obinna Chijioke, et al.
Journal for Immunotherapy of Cancer
|
January 8, 2022
Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)
Marc Wehrli, Kathleen Gallagher, Yi-Bin Chen, et al.
Cancer Cell
|
April 22, 2022
Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia
Mark B Leick, Harrison Silva, Irene Scarfò, et al.
Blood Cancer Discovery
|
January 11, 2022
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies
Stefanie R Bailey, Sonika Vatsa, Rebecca C Larson, et al.
Science Translational Medicine
|
June 5, 2024
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics
Felix Korell, Michael L Olson, Diego Salas-Benito, et al.
Blood
|
November 21, 2024
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
Harrison J Silva, Grace Martin, Filippo Birocchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 3, 2020
IgA Triggers Cell Death of Neutrophils When Primed by Inflammatory Mediators
Marc Wehrli, Christoph Schneider, Fabiola Cortinas-Elizondo, et al.
Science Translational Medicine
|
June 4, 2025
IFN-γ-resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models
Stefanie R Bailey, Hana N Takei, Giulia Escobar, et al.
Blood Advances
|
March 25, 2026
Real-world experience with Tabelecleucel within and beyond the approval label
Kiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold, et al.
Page
of 3